Table 2.

Baseline characteristics of the intervention and the control group.

Variables	Intervention group (n = 65)	Control group (n = 65)	p value
Age; mean ± SD (years)	84.9 ± 5.3	84.4 ± 5.6	0.63
n (%) men	25 (38.4%)	25 (38.4%)	1.00
CCI; mean ± SD (points)	3.66 ± 2.06	3.63 ± 1.75	0.93
ACCI; mean ± SD (points)	7.65 ± 2.34	7.66 ± 1.78	0.97
n (%) respiratory diseases	32 (49.2%)	36 (55.4%)	0.48
n (%) chronic heart failure	30 (46.9%)	32 (49.2%)	0.79
n (%) diabetes mellitus type 2	24 (36.9%)	19 (29.2%)	0.35
n (%) chronic kidney disease	25 (38.4%)	27 (41.5%)	0.72
n (%) neoplasm (all types included)	10 (15.4%)	5 (7.7%)	0.17
n (%) anemia	15 (23.1%)	18 (27.7%)	0.55
n (%) urinary tract infection	10 (15.4%)	13 (20.0%)	0.49
n (%) cognitive impairment	15 (23.1%)	13 (20.0%)	0.67

CCI: Charlson Comorbidity Index. ACCI: Age-Adjusted Charlson Comorbidity Index.